Abiopharma

News list

Goldthwaite Todd 🟡 adjusted position in 7.0K shares of Stride, Inc. (LRN) at $97.71 Transaction Date: Jul 29, 2026 | Filing ID: 000006

Full text

News bot July 31, 2026, 9:04 p.m.
🔍 Goldthwaite Todd (Executive)

Company: Stride, Inc. (LRN)

Report Date: 2026-07-29
Transaction Summary:
- Total transactions: 2
- Derivative instruments: 0
- Holdings reported: 0
- Total shares acquired: 11,040
- Total shares sold: 4,085
Detailed Transactions and Holdings:
- Acquired 11,040 shares of Common Stock (Direct)
  Date: 2026-07-29 | Code: A | equity_swap_involved: 0 | shares_owned_after: 104,546.00 | transaction_form_type: 4 | Footnotes: F1
- Sold 4,085 shares of Common Stock at $97.71 per share (Direct)
  Date: 2026-07-29 | Code: F | equity_swap_involved: 0 | shares_owned_after: 100,461.00 | transaction_form_type: 4 | Footnotes: F2
Footnotes:
- F1: Acquisition is in connection with the August 18, 2023 award and achievement of performance objectives.
- F2: Represents the number of shares withheld by the Issuer upon the vesting of restricted shares to cover the executive's withholding tax associated with the satisfaction of all vesting conditions. The number of shares withheld is based upon the closing price of a share of Stride common stock on the vesting date, or if the vesting date fell on a weekend or market holiday, upon the closing price of a share of Stride common stock on the most recent prior market day.